- Home
- AOUT vs KZIA Comparison
AOUT vs KZIA Comparison
Compare AOUT & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AOUT | KZIA |
|---|---|---|
| Founded | 2020 | 1994 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.9M | 154.9M |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | AOUT | KZIA |
|---|---|---|
| Price | $12.81 | $13.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $12.50 | ★ $19.50 |
| AVG Volume (30 Days) | 54.1K | ★ 203.1K |
| Earning Date | 03-12-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $190,536,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.26 | $4.86 |
| 52 Week High | $14.97 | $17.40 |
Technical Indicators
Market Signals| Indicator | AOUT | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 48.20 | 52.22 |
| Support Level | $12.24 | $11.39 |
| Resistance Level | $14.97 | $14.74 |
| Average True Range (ATR) | 0.50 | 1.05 |
| MACD | -0.07 | 0.09 |
| Stochastic Oscillator | 36.25 | 56.29 |
Price Performance
Historical ComparisonAbout AOUT American Outdoor Brands Inc.
American Outdoor Brands Inc is the provider of outdoor lifestyle products and shooting sports accessories encompassing hunting, fishing, meat processing, outdoor cooking, shooting, and personal security and defense products for rugged outdoor enthusiasts. It conceive, design, produce or source, and sell its outdoor lifestyle products including premium sportsman knives, land management tools, products used while hunting, meat processing equipment; and outdoor cooking products and hooting sports accessories, including rests, vaults, and other related accessories, electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips, etc. The company operate as one reporting segment.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.